Juan P. Frías
Royal Edinburgh Hospital(GB)Emergency University(US)Angeles Clinic and Research Institute(US)Fusion (United States)(US)Velocity Clinical Research (United States)(US)Fusion Academy(US)Charles R. Drew University of Medicine and Science(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Pharmacology and Obesity Treatment
Most-Cited Works
- → Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes(2021)1,723 cited
- → Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity(2021)933 cited
- → Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial(2021)931 cited
- → Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial(2023)877 cited
- → Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial(2018)774 cited
- → Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial